Drug Profile
Tretinoin - Roche
Alternative Names: Acnisdin Retinoico; All-trans retinoic acid; Arotinoid; Avita; Dermojuventus; Loderm Retinoico; NSC 122758; Retinoic acid; Retirides; Vesanoid; Vitamin A acid; Vitamin-A Acid; VitanolLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Bertek Pharmaceuticals; Ortho-McNeil; Roche
- Developer Roche
- Class Antiacnes; Antineoplastics; Cyclohexenes; Keratolytics; Retinoids; Small molecules
- Mechanism of Action Protein synthesis inhibitors; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Acne; Acne vulgaris; Acute promyelocytic leukaemia; Photodamage; Warts
- Discontinued Emphysema